De-escalation of support with veno-arterial extracorporeal membrane oxygenation and Impella for cardiogenic shock

Affiliations

¹ Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
² Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Comment

Ersilia M DeFilippis et al. Eur J Heart Fail. 2018 Mar.

. 2018 Mar;20(3):621-622.

doi: 10.1002/ejhf.953. Epub 2017 Sep 26.

¹ Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
² Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

No abstract available

Comment in

De-escalation of support with veno-arterial extracorporeal membrane oxygenation and Impella for cardiogenic shock: reply.
Schulte C, Schrage B, Pappalardo F, Westermann D. Schulte C, et al. Eur J Heart Fail. 2018 Mar;20(3):622-623. doi: 10.1002/ejhf.982. Epub 2017 Sep 25. Eur J Heart Fail. 2018. PMID: 28948707 No abstract available.

Concomitant implantation of Impella^® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock.
Pappalardo F, Schulte C, Pieri M, Schrage B, Contri R, Soeffker G, Greco T, Lembo R, Müllerleile K, Colombo A, Sydow K, De Bonis M, Wagner F, Reichenspurner H, Blankenberg S, Zangrillo A, Westermann D. Pappalardo F, et al. Eur J Heart Fail. 2017 Mar;19(3):404-412. doi: 10.1002/ejhf.668. Epub 2016 Oct 6. Eur J Heart Fail. 2017. PMID: 27709750